The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
there's a small group of people who stay inflamed and what we're we're identifying this type this this cohort of patients we call them an inflamma type that is if you draw if you take out their fluid and you look under and you look Analyze That fluid they have elevated il-1 il-6 inflammatory markers that are not coming back down to Baseline it's as if in the synovial fluid in the synovial fluid
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.